160 related articles for article (PubMed ID: 18541460)
1. Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy.
Chiron R; Grumbach YY; Quynh NV; Verriere V; Urbach V
J Cyst Fibros; 2008 Nov; 7(6):463-8. PubMed ID: 18541460
[TBL] [Abstract][Full Text] [Related]
2. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
3. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis.
Cunningham S; McColm JR; Mallinson A; Boyd I; Marshall TG
Pediatr Pulmonol; 2003 Jul; 36(1):43-8. PubMed ID: 12772222
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
[TBL] [Abstract][Full Text] [Related]
5. The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation.
Downey DG; Brockbank S; Martin SL; Ennis M; Elborn JS
Pediatr Pulmonol; 2007 Aug; 42(8):729-35. PubMed ID: 17588254
[TBL] [Abstract][Full Text] [Related]
6. Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis.
Stelmach I; Korzeniewska A; Stelmach W; Majak P; Grzelewski T; Jerzynska J
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):372-80. PubMed ID: 16279568
[TBL] [Abstract][Full Text] [Related]
7. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.
Sagel SD; Sontag MK; Wagener JS; Kapsner RK; Osberg I; Accurso FJ
J Pediatr; 2002 Dec; 141(6):811-7. PubMed ID: 12461498
[TBL] [Abstract][Full Text] [Related]
8. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
[TBL] [Abstract][Full Text] [Related]
9. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.
Kim JS; Okamoto K; Rubin BK
Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004
[TBL] [Abstract][Full Text] [Related]
12. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW
Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.
Ordoñez CL; Henig NR; Mayer-Hamblett N; Accurso FJ; Burns JL; Chmiel JF; Daines CL; Gibson RL; McNamara S; Retsch-Bogart GZ; Zeitlin PL; Aitken ML
Am J Respir Crit Care Med; 2003 Dec; 168(12):1471-5. PubMed ID: 12969869
[TBL] [Abstract][Full Text] [Related]
14. Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis.
Dakin CJ; Pereira JK; Henry RL; Wang H; Morton JR
Pediatr Pulmonol; 2002 Jun; 33(6):475-82. PubMed ID: 12001282
[TBL] [Abstract][Full Text] [Related]
15. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis.
Rozsasi A; Heinemann A; Keck T
Am J Rhinol Allergy; 2011; 25(6):e251-4. PubMed ID: 22185734
[TBL] [Abstract][Full Text] [Related]
17. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
[TBL] [Abstract][Full Text] [Related]
18. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease.
Pukhalsky AL; Shmarina GV; Kapranov NI; Kokarovtseva SN; Pukhalskaya D; Kashirskaja NJ
Mediators Inflamm; 2004 Apr; 13(2):111-7. PubMed ID: 15203552
[TBL] [Abstract][Full Text] [Related]
20. Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis.
Garner HP; Phillips JR; Herron JG; Severson SJ; Milla CE; Regelmann WE
J Lab Clin Med; 2004 Sep; 144(3):127-33. PubMed ID: 15454881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
